Assembly Biosciences, Inc. (ASMB)
Company Info
| ISIN | US0453961080 |
|---|---|
| CUSIP | 045396108 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $73.52M |
|---|---|
| EPS | -$13.38 |
| Revenue (TTM) | $7.16M |
| Gross Profit (TTM) | -$63.90M |
| EBITDA (TTM) | -$64.20M |
| Year Range | $7.69 - $20.04 |
| Target Price | $36.00 |
| Short % | 1.15% |
| Short Ratio | 2.20 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Assembly Biosciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Assembly Biosciences, Inc. had a return of 34.84% year-to-date (YTD) and 11.94% in the last 12 months. Over the past 10 years, Assembly Biosciences, Inc. had an annualized return of -14.81%, while the S&P 500 had an annualized return of 10.55%, indicating that Assembly Biosciences, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 34.84% | 6.30% |
| 1 month | 2.23% | -3.13% |
| 6 months | 26.19% | 19.37% |
| 1 year | 11.94% | 22.56% |
| 5 years (annualized) | -41.23% | 11.65% |
| 10 years (annualized) | -14.81% | 10.55% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 14.63% | 13.37% | 3.99% | |||||||||
| 2023 | -10.60% | -0.92% | -20.16% | 17.14% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Assembly Biosciences, Inc.(ASMB)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Assembly Biosciences, Inc. (ASMB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Assembly Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Assembly Biosciences, Inc. was 99.36%, occurring on Nov 22, 2023. The portfolio has not yet recovered.
The current Assembly Biosciences, Inc. drawdown is 98.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.36% | May 10, 2011 | 3157 | Nov 22, 2023 | — | — | — |
| -18.62% | Apr 6, 2011 | 5 | Apr 12, 2011 | 3 | Apr 15, 2011 | 8 |
| -14.29% | Jan 7, 2011 | 10 | Jan 21, 2011 | 20 | Feb 18, 2011 | 30 |
| -11.37% | Mar 16, 2011 | 4 | Mar 21, 2011 | 8 | Mar 31, 2011 | 12 |
| -6.41% | Mar 2, 2011 | 4 | Mar 7, 2011 | 2 | Mar 9, 2011 | 6 |
Volatility
Volatility Chart
The current Assembly Biosciences, Inc. volatility is 16.25%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |